Cargando…

Comprehensive Analysis of Common Serum Liver Enzymes as Prospective Predictors of Hepatocellular Carcinoma in HBV Patients

BACKGROUND: Serum liver enzymes are frequently tested in clinics to aid disease diagnosis. Large observational studies indicated that these enzymes might predict cancer risk and mortality. However, no prospective study has reported on their relationships with the risk of HBV-related hepatocellular c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hann, Hie-Won, Wan, Shaogui, Myers, Ronald E., Hann, Richard S., Xing, Jinliang, Chen, Bicui, Yang, Hushan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480412/ https://www.ncbi.nlm.nih.gov/pubmed/23112834 http://dx.doi.org/10.1371/journal.pone.0047687

Ejemplares similares

Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection
por: Li, Ling, et al.
Publicado: (2016)

Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
por: Yoo, Joseph, et al.
Publicado: (2018)

Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma
por: Wan, Shaogui, et al.
Publicado: (2015)

A long-term study of the effects of antiviral therapy on survival of patients with HBV-associated hepatocellular carcinoma (HCC) following local tumor ablation
por: Hann, Hie-Won, et al.
Publicado: (2014)

Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies – results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers
por: Wan, Shaogui, et al.
Publicado: (2013)

Ferritin level prospectively predicts hepatocarcinogenesis in patients with chronic hepatitis B virus infection
por: Bian, Zhenyuan, et al.
Publicado: (2018)

Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series
por: Bashir Hamidu, Rukaiya, et al.
Publicado: (2021)

Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study
por: Lin, Selena Y., et al.
Publicado: (2023)

Hepatitis B Virus-Associated Hepatocellular Carcinoma and Chronic Stress
por: Noverati, Nicholas, et al.
Publicado: (2022)

Hepatitis B-related hepatocellular carcinoma and stress: untangling the host immune response from clinical outcomes
por: Block, Peter D, et al.
Publicado: (2020)

Genetic Polymorphism in a VEGF-Independent Angiogenesis Gene ANGPT1 and Overall Survival of Colorectal Cancer Patients after Surgical Resection
por: Dai, Jingyao, et al.
Publicado: (2012)

The Role of Host in the Spectrum of Outcomes in Family Clusters of Hepatitis Infection: From Asymptomatic to Hepatocellular Carcinoma
por: Noverati, Nicholas, et al.
Publicado: (2023)

Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection
por: Chae, Hee Bok, et al.
Publicado: (2007)

Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level
por: Force, Madison, et al.
Publicado: (2022)

Genetic variations in genes of metabolic enzymes predict postoperational prognosis of patients with colorectal cancer
por: Dong, Guanglong, et al.
Publicado: (2015)

Perioperative predictors of outcome of hepatectomy for HBV-related hepatocellular carcinoma
por: He, Ziming, et al.
Publicado: (2023)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients
por: Yuan, Peng, et al.
Publicado: (2014)

Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma
por: Zhao, Jing, et al.
Publicado: (2019)

Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
por: Shinn, Brianna J, et al.
Publicado: (2019)

A Meta-Analysis of Array-CGH Studies Implicates Antiviral Immunity Pathways in the Development of Hepatocellular Carcinoma
por: Guo, Xu, et al.
Publicado: (2011)

Serum/Plasma MicroRNAs as Biomarkers for HBV-Related Hepatocellular Carcinoma in China
por: Yin, Wen, et al.
Publicado: (2015)

Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma
por: Zhu, Hao-Tu, et al.
Publicado: (2016)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC
por: Wei, Yanyan, et al.
Publicado: (2018)

Serum miR-375 Levels Are Closely Related to Disease Progression from HBV Infection to HBV-Related Hepatocellular Carcinoma
por: Zhang, Weilu, et al.
Publicado: (2020)

Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV-associated hepatocellular carcinoma
por: Zhang, Lijie, et al.
Publicado: (2020)

Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma
por: Wang, Kang, et al.
Publicado: (2015)

Association between four common microRNA polymorphisms and the risk of hepatocellular carcinoma and HBV infection
por: KOU, JIAN-TAO, et al.
Publicado: (2014)

Single nucleotide polymorphisms as the new predictors of therapy decisions in gastroesophageal junction and gastric adenocarcinoma?
por: Perkhofer, Lukas, et al.
Publicado: (2019)

Comprehensive investigation of cytokine- and immune-related gene variants in HBV-associated hepatocellular carcinoma patients
por: Yu, Fengxue, et al.
Publicado: (2017)

A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma
por: Sun, Suofeng, et al.
Publicado: (2019)

Serum HBV RNA is a Potential Predictor of Hepatitis B Surface Antigen Reversion
por: Wang, Jie, et al.
Publicado: (2018)

Machine learning-based genome-wide interrogation of somatic copy number aberrations in circulating tumor DNA for early detection of hepatocellular carcinoma
por: Tao, Kaishan, et al.
Publicado: (2020)

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
por: Jiang, Yu, et al.
Publicado: (2021)

Medical interventions associated with HBV reactivation: Common and less common
por: Reynolds, Justin A., et al.
Publicado: (2015)

Comprehensive Analysis Identified ASF1B as an Independent Prognostic Factor for HBV-Infected Hepatocellular Carcinoma
por: Wang, Xianmo, et al.
Publicado: (2022)

TNFα induces Ca(2+) influx to accelerate extrinsic apoptosis in hepatocellular carcinoma cells
por: Zhu, Jianjun, et al.
Publicado: (2018)

Serum Amino Acid Profiles Predict the Development of Hepatocellular Carcinoma in Patients with Chronic HBV Infection
por: Wu, Tao, et al.
Publicado: (2022)

Serum soluble DR5 predicts mortality risk in patients with HBV-related hepatocellular carcinoma
por: Liang, Jiaqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aamukjfbeidsce5s1i5prgp546